Rarely, patients with systemic lupus erythematosus (SLE) develop bullous eruptions, a disease called bullous SLE in a narrow sense that has autoantibodies against type VII collagen. We describe an unusual case in which a patient with SLE developed extensive bullae on her lower extremities. Histologically, the bullous lesions were suggestive of leukocytoclastic vasculitis with deposition of C3 within blood vessel walls. Immunoblot analyses and enzyme-linked immunosorbent assays were negative for anti-type VII collagen antibodies. We initially considered bullous SLE, but eventually made a diagnosis of secondary vasculitis in SLE. The oral prednisolone dose was increased, and the vesiculobullous lesions resolved. The clinical presentations of cutaneous vasculitis in SLE include palpable purpura, petechiae, papulonodular lesions, and livedo reticularis. Bullous lesions seem to be uncommon. Physicians need to be aware that extensive bullae can occur as a result of secondary vasculitis in SLE, even if the patient does not exhibit high disease activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525288PMC
http://dx.doi.org/10.1159/000519022DOI Listing

Publication Analysis

Top Keywords

bullous sle
12
vasculitis sle
12
systemic lupus
8
lupus erythematosus
8
leukocytoclastic vasculitis
8
sle
8
vii collagen
8
extensive bullae
8
bullous lesions
8
secondary vasculitis
8

Similar Publications

Drug-induced lupus erythematosus (DILE) is an autoimmune reaction that results in symptoms of polyarthralgia, fever, and cutaneous lesions and other manifestations. Several drugs have been documented to cause this disease, including procainamide, isoniazid, methyldopa, penicillamine, and hydralazine. Systemic lupus erythematosus (SLE) manifestations often occur after the patient has been taking the drug without complications for months to years.

View Article and Find Full Text PDF

Background: Systemic Lupus Erythematosus (SLE) (C1) is a disease with multi-organ involvement that can have a variety of cutaneous manifestations in 76% of cases during the disease. Less than 1% of these patients are diagnosed with confirmed bullous systemic lupus erythematosus (C1). Given the wide differential diagnosis of a bullous lesion, it is imperative to reach a conclusive diagnosis as it can have a direct impact on the course of management of the disease.

View Article and Find Full Text PDF

Aim: Increasing observational studies are revealing a positive correlation between body mass index (BMI) and the risk of Immune-mediated and Inflammatory Skin Diseases (IMID), however the causal relationship is not yet definite.

Objective: The aim of the study was to conduct a two-sample Mendelian randomization (TSMR) to explore the potential causality between BMI, and IMID and biomarkers.

Methods: The summary statistics for BMI (n = 322,154), at genome-wide significant level, were derived from the Genetic Investigation of Anthropometric Traits consortium (GIANT).

View Article and Find Full Text PDF
Article Synopsis
  • The American Gastroenterological Association (AGA) commissioned this expert review to provide guidance on diagnosing infectious and immune-mediated esophageal disorders, which are often under-recognized and lead to dysfunction and health costs.
  • The review offers Best Practice Advice (BPA) statements based on published literature and expert opinions, but lacks formal evidence ratings due to the absence of systematic reviews.
  • Increased awareness among gastroenterologists regarding these disorders can enhance patient care by improving diagnosis and limiting unnecessary medical procedures, particularly in patients presenting with dysphagia, heartburn, and odynophagia.
View Article and Find Full Text PDF

Two-sample Mendelian randomization analysis of causal relationship between eczema and autoimmune diseases.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

June 2024

Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha 410013.

Article Synopsis
  • This study investigates whether there is a causal relationship between eczema and various autoimmune diseases, using a technique called Mendelian randomization to analyze genetic data.
  • Findings reveal that genetic susceptibility to eczema is linked to an increased risk of Crohn's disease and ulcerative colitis, but not to other autoimmune diseases like systemic lupus erythematosus or multiple sclerosis.
  • The research concludes that while eczema is associated with certain autoimmune conditions, it doesn't have a causal influence on many others, and there's no evidence of autoimmune diseases causing eczema.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!